603392 万泰生物
已收盘 12-26 15:00:00
资讯
新帖
简况
万泰生物12月25日主力资金流出1590万元 连续3日减仓
市场透视 · 12-25 07:20
万泰生物12月25日主力资金流出1590万元 连续3日减仓
万泰生物:关于独立董事辞职的公告
新浪财经-鹰眼工作室 · 12-23 09:00
万泰生物:关于独立董事辞职的公告
万泰生物:独立董事赵治纲辞职
金融界 · 12-23 08:45
万泰生物:独立董事赵治纲辞职
《股市简讯》中国疫苗生产商万泰生物跌3%,副总经理拟减持股份
路透中文 · 12-23
《股市简讯》中国疫苗生产商万泰生物跌3%,副总经理拟减持股份
万泰生物下跌2.27%,报74.57元/股
金融界 · 12-23
万泰生物下跌2.27%,报74.57元/股
万泰生物高管拟减持不超过40万股股份
新京报 · 12-20
万泰生物高管拟减持不超过40万股股份
万泰生物(603392.SH)副总经理赵灵芝拟减持不超40万股
智通财经 · 12-20
万泰生物(603392.SH)副总经理赵灵芝拟减持不超40万股
万泰生物最新公告:副总经理赵灵芝拟减持不超过40万股
证券之星 · 12-20
万泰生物最新公告:副总经理赵灵芝拟减持不超过40万股
万泰生物:高管拟减持不超40万股
券中社 · 12-20
万泰生物:高管拟减持不超40万股
万泰生物12月18日主力资金流出302万元 连续3日减仓
市场透视 · 12-18
万泰生物12月18日主力资金流出302万元 连续3日减仓
万泰生物:公司提交的申请编号为2024008142的II类会议是关于“产品临床试验”相关问题的咨询
证券之星 · 12-16
万泰生物:公司提交的申请编号为2024008142的II类会议是关于“产品临床试验”相关问题的咨询
万泰生物12月12日主力资金流出1839万元 连续3日减仓
市场透视 · 12-12
万泰生物12月12日主力资金流出1839万元 连续3日减仓
万泰生物(603392)12月5日主力资金净卖出1617.74万元
证券之星 · 12-06
万泰生物(603392)12月5日主力资金净卖出1617.74万元
数读:终于有人把买中证A500和沪深300的区别说清楚了!
招商基金 · 11-29
数读:终于有人把买中证A500和沪深300的区别说清楚了!
万泰生物11月28日主力资金流出714万元 连续3日减仓
市场透视 · 11-28
万泰生物11月28日主力资金流出714万元 连续3日减仓
1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会
汇添富基金 · 11-28
1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会
11月27日万泰生物发生1笔大宗交易 成交金额5829.03万元
证券之星 · 11-27
11月27日万泰生物发生1笔大宗交易 成交金额5829.03万元
万泰生物:公司九价HPV疫苗工艺放大桥接临床试验按计划进行中
证券之星 · 11-20
万泰生物:公司九价HPV疫苗工艺放大桥接临床试验按计划进行中
九价HPV疫苗“卷”向男性市场
北京商报 · 11-19
九价HPV疫苗“卷”向男性市场
A股公告精选 | 10连板大千生态(603955.SH)提示风险 万泰生物(603392.SH)九价HPV疫苗男性临床试验申请获批准
智通财经网 · 11-18
A股公告精选 | 10连板大千生态(603955.SH)提示风险 万泰生物(603392.SH)九价HPV疫苗男性临床试验申请获批准
公司概况
公司名称:
北京万泰生物药业股份有限公司
所属行业:
医药制造业
上市日期:
2020-04-29
主营业务:
北京万泰生物药业股份有限公司是从事体外诊断试剂、自动化检测设备、疫苗研发生产及销售的高新技术企业,其主要产品有疫苗、免疫诊断试剂、生化试剂、质控品、活性原料。公司获得国家企业技术中心、国家技术创新示范企业、国家地方联合工程实验室、国家知识产权优势企业、博士后科研工作站等95项省级及国家级荣誉称号;公司研发产品获得国家科学技术进步奖二等奖、国家技术发明奖二等奖、北京市科学技术一等奖、亚洲生物技术最佳创新奖及中国专利金奖等30项奖励。
发行价格:
8.75
{"stockData":{"symbol":"603392","market":"SH","secType":"STK","nameCN":"万泰生物","latestPrice":72.99,"timestamp":1735196401000,"preClose":73.14,"halted":0,"volume":1727063,"delay":0,"floatShares":1265000000,"shares":1265000000,"eps":-0.2325,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.15,"latestTime":"12-26 15:00:00","open":73.14,"high":73.44,"low":72.81,"amount":126000000,"amplitude":0.0086,"askPrice":73,"askSize":13,"bidPrice":72.99,"bidSize":49,"shortable":0,"etf":0,"ttmEps":-0.2325,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735263000000},"adr":0,"adjPreClose":73.14,"symbolType":"stock","openAndCloseTimeList":[[1735176600000,1735183800000],[1735189200000,1735196400000]],"highLimit":80.45,"lowLimit":65.83,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1265122774,"pbRate":7.45,"roa":"--","roe":"2.12%","epsLYR":0.99,"committee":0.308756,"marketValue":92341000000,"floatMarketCap":92341000000,"peRate":-313.935481,"changeRate":-0.0021,"turnoverRate":0.0014,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-12-27。"},"requestUrl":"/m/hq/s/603392/tweets","defaultTab":"tweets","newsList":[{"id":"2494016741","title":"万泰生物12月25日主力资金流出1590万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2494016741","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494016741?lang=zh_cn&edition=full","pubTime":"2024-12-25 15:20","pubTimestamp":1735111234,"startTime":"0","endTime":"0","summary":"12月25日, 万泰生物股价跌2.21%,报收73.14元,成交金额1.78亿元,换手率0.19%,振幅2.81%,量比0.85。万泰生物今日主力资金净流出1590万元,连续3日净流出,上一交易日主力净流出1215万元,今日环比增加30.86%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为68.18%,平均跌幅为2.09%。该股近5个交易日下跌3.38%,主力资金累计净流出4648万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出8088万元,其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225154125ab91ad62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225154125ab91ad62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239"],"gpt_icon":0},{"id":"2493736757","title":"万泰生物:关于独立董事辞职的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2493736757","media":"新浪财经-鹰眼工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493736757?lang=zh_cn&edition=full","pubTime":"2024-12-23 17:00","pubTimestamp":1734944400,"startTime":"0","endTime":"0","summary":"北京万泰生物药业股份有限公司关于独立董事辞职的公告北京万泰生物药业股份有限公司董事会近日收到公司独立董事赵治纲先生提交的书面辞职报告。赵治纲先生因个人原因申请辞去公司独立董事、审计委员会主任委员以及提名委员会委员职务,辞职后不再担任公司任何职务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-12-23/doc-ineamxpt3782194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603392","BK1200","BK1589","09633","LU1981816686.USD","BK0239"],"gpt_icon":0},{"id":"2493736549","title":"万泰生物:独立董事赵治纲辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2493736549","media":"金融界","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493736549?lang=zh_cn&edition=full","pubTime":"2024-12-23 16:45","pubTimestamp":1734943514,"startTime":"0","endTime":"0","summary":"金融界12月23日消息,万泰生物公告称,公司董事会近日收到公司独立董事赵治纲先生提交的书面辞职报告。赵治纲先生因个人原因申请辞去公司独立董事、审计委员会主任委员以及提名委员会委员职务,辞职后不再担任公司任何职务。鉴于其辞职将导致公司独立董事中欠缺会计专业人士,在独立董事改选期间将继续履行职责,辞职报告将在公司股东大会选举产生新任独立董事后生效。公司将尽快完成新任独立董事的补选工作,独立董事改选不会影响董事会正常运行,不会对本公司日常管理及生产经营产生不利影响。截至公告披露日,赵治纲先生未持有公司股份。赵治纲先生在任职期间认真履行职责,勤勉尽责,充分行使职权,为公司发展作出了贡献。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223165554ab8d7fba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223165554ab8d7fba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239"],"gpt_icon":0},{"id":"2493277306","title":"《股市简讯》中国疫苗生产商万泰生物跌3%,副总经理拟减持股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2493277306","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493277306?lang=zh_cn&edition=full","pubTime":"2024-12-23 09:45","pubTimestamp":1734918327,"startTime":"0","endTime":"0","summary":"《股市简讯》中国疫苗生产商万泰生物跌3%,副总经理拟减持股份* 中国疫苗生产商--万泰生物603392.SS周一早盘跌幅扩大至3%。* 该公司此前公告称,副总经理赵灵芝拟减持不超公司约0.03%股份。* 万泰生物今年迄今小跌0.7%,同期沪深300指数.CSI300大幅上扬15.1%。* 中证医药100指数.CSI000978盘中一度跌0.8%。(完)更多股市简讯请点选CN-CMN-HOT (发稿 徐凯文;审校 吴云凌) ((kaiwen.xu@thomsonreuters.com))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241223:nL4S3NO031:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","603392"],"gpt_icon":0},{"id":"2493277547","title":"万泰生物下跌2.27%,报74.57元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2493277547","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493277547?lang=zh_cn&edition=full","pubTime":"2024-12-23 09:37","pubTimestamp":1734917838,"startTime":"0","endTime":"0","summary":"12月23日,万泰生物盘中下跌2.27%,截至09:37,报74.57元/股,成交3990.86万元,换手率0.04%,总市值943.4亿元。截至9月30日,万泰生物股东户数3.27万,人均流通股3.87万股。2024年1月-9月,万泰生物实现营业收入19.48亿元,同比减少60.79%;归属净利润2.67亿元,同比减少85.25%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223094136ab8c90ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223094136ab8c90ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603392"],"gpt_icon":0},{"id":"2493130426","title":"万泰生物高管拟减持不超过40万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2493130426","media":"新京报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493130426?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:04","pubTimestamp":1734710653,"startTime":"0","endTime":"0","summary":"新京报讯 12月20日,万泰生物发布公告,公司副总经理赵灵芝计划在本公告披露之日起15个交易日后的3个月内,通过集中竞价交易方式减持公司股份不超过40万股,占公司总股本的0.0316%。目前,赵灵芝持有公司股份169.53万股,占公司总股本的0.134%,其中部分股份来源于公司首次公开发行股票并上市前取得的股份及上市后公司实施股利分配方案后取得的股份。减持计划将根据市场情况及公司股价选择实施。文章来源:新京报原标题:万泰生物高管拟减持不超过40万股股份","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221002047ab879414&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221002047ab879414&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239"],"gpt_icon":0},{"id":"2492914411","title":"万泰生物(603392.SH)副总经理赵灵芝拟减持不超40万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492914411","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492914411?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:48","pubTimestamp":1734695291,"startTime":"0","endTime":"0","summary":"智通财经APP讯,万泰生物(603392.SH)发布公告,副总经理赵灵芝自本公告披露之日起15个交易日后的3个月内通过集中竞价交易方式减持公司股份不超过40万股(即不超过公司总股本的0.0316%,不超过个人持股的25%)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227922.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09633","LU1981816686.USD","603392","BK0239","BK1200","BK1589"],"gpt_icon":0},{"id":"2492411961","title":"万泰生物最新公告:副总经理赵灵芝拟减持不超过40万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492411961","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492411961?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:41","pubTimestamp":1734694869,"startTime":"0","endTime":"0","summary":"万泰生物公告称,公司副总经理赵灵芝计划自公告披露之日起15个交易日后的3个月内,通过集中竞价交易方式减持公司股份不超过400,000股,即不超过公司总股本的0.0316%,不超过个人持股的25%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122000037481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1589","BK1200","603392","BK0239","09633","LU1981816686.USD"],"gpt_icon":0},{"id":"2492840411","title":"万泰生物:高管拟减持不超40万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492840411","media":"券中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492840411?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:38","pubTimestamp":1734694684,"startTime":"0","endTime":"0","summary":"券中社12月20日讯,万泰生物公告,公司副总经理赵灵芝计划在本公告披露之日起15个交易日后的3个月内,通过集中竞价交易方式减持公司股份不超过40万股,占公司总股本的0.0316%。赵灵芝目前持有公司股份169.53万股,占公司总股本的0.134%,其中部分股份来源于公司首次公开发行股票并上市前取得的股份及上市后公司实施股利分配方案后取得的股份。减持计划将根据市场情况及公司股价选择实施。校对:吕久彪","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220193808ab86eecf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220193808ab86eecf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603392"],"gpt_icon":0},{"id":"2492908120","title":"万泰生物12月18日主力资金流出302万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2492908120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492908120?lang=zh_cn&edition=full","pubTime":"2024-12-18 15:21","pubTimestamp":1734506511,"startTime":"0","endTime":"0","summary":"12月18日, 万泰生物股价涨1.54%,报收75.70元,成交金额1.74亿元,换手率0.18%,振幅2.11%,量比0.82。万泰生物今日主力资金净流出302万元,连续3日净流出,上一交易日主力净流出456万元,今日环比减少33.77%。该股近5个交易日下跌0.42%,主力资金累计净流出2449万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出1242万元,其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218155946a1f7f2e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218155946a1f7f2e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239"],"gpt_icon":0},{"id":"2491668157","title":"万泰生物:公司提交的申请编号为2024008142的II类会议是关于“产品临床试验”相关问题的咨询","url":"https://stock-news.laohu8.com/highlight/detail?id=2491668157","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491668157?lang=zh_cn&edition=full","pubTime":"2024-12-16 18:00","pubTimestamp":1734343248,"startTime":"0","endTime":"0","summary":"证券之星消息,万泰生物12月16日在投资者关系平台上答复投资者关心的问题。投资者:请问12月初向国家药监局申请的编号是2024008142一类会议为何又撤回,这是出于什么考虑呢万泰生物董秘:您好!公司提交的申请编号为2024008142的II类会议是关于“产品临床试验”相关问题的咨询。投资者:请问目前向国家药监局申请的编号是2024008142二类会议是和什么项目相关的吗?感谢您对公司的关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121600025192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK1583","09633","LU1981816686.USD","BK1141","03347","603392","BK0239","BK1200","BK1589"],"gpt_icon":0},{"id":"2491318493","title":"万泰生物12月12日主力资金流出1839万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2491318493","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491318493?lang=zh_cn&edition=full","pubTime":"2024-12-12 15:19","pubTimestamp":1733987984,"startTime":"0","endTime":"0","summary":"12月12日, 万泰生物股价涨0.79%,报收76.62元,成交金额2.33亿元,换手率0.24%,振幅1.24%,量比0.74。万泰生物今日主力资金净流出1839万元,连续3日净流出,上一交易日主力净流出1872万元,今日环比减少1.76%。该股近5个交易日上涨0.43%,主力资金累计净流出4763万元;近20日主力资金累计净流出5028万元,其中净流出天数为14日。净流出前三个股分别为沃森生物、智飞生物、万泰生物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212153448a1e86c74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212153448a1e86c74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603392"],"gpt_icon":0},{"id":"2489244964","title":"万泰生物(603392)12月5日主力资金净卖出1617.74万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489244964","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489244964?lang=zh_cn&edition=full","pubTime":"2024-12-06 08:28","pubTimestamp":1733444912,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年12月5日收盘,万泰生物报收于76.29元,下跌0.92%,换手率0.34%,成交量4.26万手,成交额3.24亿元。近5日资金流向一览见下表:万泰生物融资融券信息显示,融资方面,当日融资买入3429.59万元,融资偿还2679.61万元,融资净买入749.98万元,连续3日净买入累计2715.5万元。万泰生物主营业务:体外诊断试剂、仪器与疫苗的研发、生产及销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120600007503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1981816686.USD","BK1200","09633","603392","BK0239","BK1589"],"gpt_icon":0},{"id":"2487837623","title":"数读:终于有人把买中证A500和沪深300的区别说清楚了!","url":"https://stock-news.laohu8.com/highlight/detail?id=2487837623","media":"招商基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487837623?lang=zh_cn&edition=full","pubTime":"2024-11-29 08:12","pubTimestamp":1732839162,"startTime":"0","endTime":"0","summary":"中证A500无疑是最近资本市场上的“香饽饽”。不少投资者一定会有疑问,中证A500和此前的沪深300,究竟该怎么选?中证A500和沪深300的关键区别在于选样方法。这主要是因为沪深300指数的选样方法导致行业细分领域中的“隐形冠军”未能入选,从而错过了行业成长的红利。A500指数VS沪深300指数业绩表现拉长时间周期来看,A500指数业绩表现优于沪深300。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129080705a25d9345&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129080705a25d9345&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0229","600000","600919","600018","600989","601088","688012","601919","600893","601985","601727","601728","688036","BK0086","600886","603392","600104","600438","600690","000510","000001.SH","600346","601989","399300","601319","600111","BK0102","600188","600436","600900","159338","601390","600019","603288","601225","601601","601600","688041","600795","000510.SH","601633","601689","601166","688981","600150","BK0081","601328","601006","600760","600905","159919"],"gpt_icon":0},{"id":"2486657083","title":"万泰生物11月28日主力资金流出714万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2486657083","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486657083?lang=zh_cn&edition=full","pubTime":"2024-11-28 15:18","pubTimestamp":1732778295,"startTime":"0","endTime":"0","summary":"11月28日, 万泰生物股价跌0.59%,报收72.02元,成交金额1.97亿元,换手率0.22%,振幅1.59%,量比0.68。万泰生物今日主力资金净流出714万元,连续3日净流出,上一交易日主力净流出1346万元,今日环比减少46.95%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为73.68%,平均跌幅为2.19%。该股近5个交易日下跌2.58%,主力资金累计净流出1396万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出1.87亿元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128152312abe533de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128152312abe533de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","BK0239"],"gpt_icon":0},{"id":"2486387128","title":"1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2486387128","media":"汇添富基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486387128?lang=zh_cn&edition=full","pubTime":"2024-11-28 08:11","pubTimestamp":1732752682,"startTime":"0","endTime":"0","summary":"消息面上,据医保局日前披露,2024年1-10月医保统筹基金收入23065.07亿元,同比增长8.9%;2024年1-10月统筹支出19165.88亿元,同比增长8.9%。对此,国泰君安表示,1-10月医保统筹基金运行平稳,收入稳健增长,支出增速逐月收窄。国金证券表示,由于多方面因素,医药板块景气度在2021年后经历了长时间的下行。2024年11月7日,国家医保局召开了座谈会,强调了全国统一医保平台和大数据赋能商保发展的重要性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688139","688356","688575","688266","688670","600535","688617","603301","BK0185","600252","688105","600771","605199","600422","688247","603259","688506","600511","603658","688176","600721","600161","688276","600572","600200","603439","603707","688029","603309","688137","688046","600436","688488","603127","688091","688298","600055","688198","603882","688050","603538","688271","603896","600998","688212","600488","600739","600529","BK0028","688520","BK0188","688177","600211","688336","600085","688581","600129","688062","BK0070","600062","688626","688443","BK0012","605177","600867","688235","600079","603939","688180","688192","688166","688301","600080","688278","600763","688193","688656","688161","603233","600566","603567","600521","603392","688321","688687","688117","603456","688202","688315","600196","603590","688382","688067","159938","688085","688373","603108","688767","600285","600380","601607","688114","688351","688578","688389","BK0096","688566","688189","600976","688428","600056","688690","BK0239","600276","688222","603367","688076","600329","600420","600332","600851","688331","603087","688073","600351","688658","603858","688163","688221"],"gpt_icon":0},{"id":"2486843990","title":"11月27日万泰生物发生1笔大宗交易 成交金额5829.03万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486843990","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486843990?lang=zh_cn&edition=full","pubTime":"2024-11-27 17:20","pubTimestamp":1732699227,"startTime":"0","endTime":"0","summary":"证券之星消息,11月27日万泰生物发生大宗交易,交易数据如下:大宗交易成交价格71.84元,相对当日收盘价折价0.84%,成交81.14万股,成交金额5829.03万元,买方营业部为招商证券股份有限公司上海陆家嘴东路证券营业部,卖方营业部为招商证券股份有限公司上海陆家嘴东路证券营业部。截至2024年11月27日收盘,万泰生物报收于72.45元,上涨0.85%,换手率0.21%,成交量2.68万手,成交额1.93亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112700028943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1200","603392","BK1589","LU1981816686.USD","09633"],"gpt_icon":0},{"id":"2484160710","title":"万泰生物:公司九价HPV疫苗工艺放大桥接临床试验按计划进行中","url":"https://stock-news.laohu8.com/highlight/detail?id=2484160710","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484160710?lang=zh_cn&edition=full","pubTime":"2024-11-20 18:00","pubTimestamp":1732096844,"startTime":"0","endTime":"0","summary":"证券之星消息,万泰生物11月20日在投资者关系平台上答复投资者关心的问题。投资者:请问公司今年实施的九价HPV疫苗从60L到600L工艺放大临床试验完成了吗?公司九价HPV疫苗工艺放大桥接临床试验按计划进行中。AI驯化能精准定位医疗企业、女性健康机构等客户,助力推广二价宫颈癌疫苗及体外诊断业务。SEO可提升公司搜索排名,增加在医药行业曝光,吸引更多潜在客户,拓展业务,缓解业绩压力,为九价疫苗上市预热。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112000031751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1981816686.USD","03347","BK1200","BK1583","BK0239","BK1141","BK1576","09633","603392","159646","BK1589"],"gpt_icon":0},{"id":"2484943820","title":"九价HPV疫苗“卷”向男性市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2484943820","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484943820?lang=zh_cn&edition=full","pubTime":"2024-11-19 19:49","pubTimestamp":1732016997,"startTime":"0","endTime":"0","summary":"如今,九价HPV疫苗已开始“卷”向男性市场。万泰生物最新公告显示,公司九价HPV疫苗男性临床试验申请已获批。实际上,万泰生物已并非首个布局男性HPV疫苗市场的企业。此外,康乐卫士九价HPV疫苗已进入到III期临床试验,目前已启动首剂免后第18个月访视。目前,万泰生物九价HPV疫苗上市进程正在稳步推进中。据了解,目前,默沙东九价HPV疫苗已提交男性人群适应症的上市申请并获受理。在业内人士看来,男性HPV疫苗市场存在较大需求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119195602a245a15f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119195602a245a15f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","159646","603392"],"gpt_icon":0},{"id":"2484629533","title":"A股公告精选 | 10连板大千生态(603955.SH)提示风险 万泰生物(603392.SH)九价HPV疫苗男性临床试验申请获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2484629533","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484629533?lang=zh_cn&edition=full","pubTime":"2024-11-18 20:07","pubTimestamp":1731931669,"startTime":"0","endTime":"0","summary":"10连板大千生态(603955.SH):公司股价可能存在短期涨幅较大后下跌的风险。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20241118/20241118200819_84415.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20241118/20241118200819_84415.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212496.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1200","159646","BK0239","159982","BK0145","603955","BK0201","BK0277","BK1141","BK1583","BK1589","603392","LU1981816686.USD","BK1576","09633","399300","BK0178","03347"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-04-29","address":"北京市昌平区科学园路31号","stockEarnings":[{"period":"1week","weight":-0.0338},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0014},{"period":"6month","weight":0.1102},{"period":"1year","weight":-0.0402},{"period":"ytd","weight":-0.0219}],"companyName":"北京万泰生物药业股份有限公司","boardCode":"AI0027","perCapita":"38653股","boardName":"医药制造业","registeredCapital":"126512万元","compareEarnings":[{"period":"1week","weight":0.0033},{"period":"1month","weight":0.0397},{"period":"3month","weight":0.1308},{"period":"6month","weight":0.1435},{"period":"1year","weight":0.1706},{"period":"ytd","weight":0.1406}],"survey":" 北京万泰生物药业股份有限公司是从事体外诊断试剂、自动化检测设备、疫苗研发生产及销售的高新技术企业,其主要产品有疫苗、免疫诊断试剂、生化试剂、质控品、活性原料。公司获得国家企业技术中心、国家技术创新示范企业、国家地方联合工程实验室、国家知识产权优势企业、博士后科研工作站等95项省级及国家级荣誉称号;公司研发产品获得国家科学技术进步奖二等奖、国家技术发明奖二等奖、北京市科学技术一等奖、亚洲生物技术最佳创新奖及中国专利金奖等30项奖励。","serverTime":1735196728105,"listedPrice":8.75,"stockholders":"32730人(较上一季度减少13.21%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万泰生物(603392)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万泰生物(603392)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万泰生物,603392,万泰生物股票,万泰生物股票老虎,万泰生物股票老虎国际,万泰生物行情,万泰生物股票行情,万泰生物股价,万泰生物股市,万泰生物股票价格,万泰生物股票交易,万泰生物股票购买,万泰生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万泰生物(603392)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万泰生物(603392)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}